Your browser doesn't support javascript.
loading
Re: Chen Dong, Sung-Lang Chen, and Wen-Wei Sung's Letter to the Editor re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285-93.
Welen, Karin; Rosendal, Ebba; Freyhult, Eva; Fors Connolly, Anne-Marie; Överby, Anna K; Josefsson, Andreas.
Affiliation
  • Welen K; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Rosendal E; Department of Clinical Microbiology, Umeå University, Umeå, Sweden.
  • Freyhult E; Department of Medical Sciences, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Fors Connolly AM; Department of Clinical Microbiology, Umeå University, Umeå, Sweden; The Laboratory for Molecular Infection Medicine Sweden, Umeå, Sweden.
  • Överby AK; Department of Clinical Microbiology, Umeå University, Umeå, Sweden; The Laboratory for Molecular Infection Medicine Sweden, Umeå, Sweden.
  • Josefsson A; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Surgical and Perioperative Sciences, Urology & Andrology, Umeå University, Umeå, Sweden; Wallenberg Center for Molecular Medicine, Umeå University, Umeå, Sweden
Eur Urol ; 81(5): e124-e125, 2022 05.
Article in En | MEDLINE | ID: mdl-35168845

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Drug Treatment / Androgen Antagonists Type of study: Screening_studies Limits: Humans Language: En Journal: Eur Urol Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Drug Treatment / Androgen Antagonists Type of study: Screening_studies Limits: Humans Language: En Journal: Eur Urol Year: 2022 Document type: Article